These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 6208607)

  • 21. A molecular clone of HTLV-III with biological activity.
    Fisher AG; Collalti E; Ratner L; Gallo RC; Wong-Staal F
    Nature; 1985 Jul 18-24; 316(6025):262-5. PubMed ID: 2410792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuous production of a cytopathic human T-lymphotropic virus in a permissive neoplastic T-cell line.
    Getchell JP; Heath JL; Hicks DR; Sporborg C; McGrath CR; Kalyanaraman VS
    J Clin Microbiol; 1986 Apr; 23(4):737-42. PubMed ID: 2422205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential response to the cytopathic effects of human T-cell lymphotropic virus type III (HTLV-III) superinfection in T4+ (helper) and T8+ (suppressor) T-cell clones transformed by HTLV-I.
    De Rossi A; Franchini G; Aldovini A; Del Mistro A; Chieco-Bianchi L; Gallo RC; Wong-Staal F
    Proc Natl Acad Sci U S A; 1986 Jun; 83(12):4297-301. PubMed ID: 2424024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human T-cell leukemia virus: its discovery and role in leukemogenesis and immunosuppression.
    Shaw GM; Broder S; Essex M; Gallo RC
    Adv Intern Med; 1984; 30():1-27. PubMed ID: 6084947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serological relationship between reverse transcriptases from human T-cell lymphotropic viruses defined by monoclonal antibodies. Evidence for two forms of reverse transcriptases in the AIDS-associated virus, HTLV-III/LAV.
    Chandra A; Gerber T; Kaul S; Wolf C; Demirhan I; Chandra P
    FEBS Lett; 1986 May; 200(2):327-32. PubMed ID: 2423366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term cultures of HTLV-III--infected T cells: a model of cytopathology of T-cell depletion in AIDS.
    Zagury D; Bernard J; Leonard R; Cheynier R; Feldman M; Sarin PS; Gallo RC
    Science; 1986 Feb; 231(4740):850-3. PubMed ID: 2418502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human T-cell leukemia/lymphotropic virus type III in the conjunctival epithelium of a patient with AIDS.
    Fujikawa LS; Salahuddin SZ; Ablashi D; Palestine AG; Masur H; Nussenblatt RB; Gallo RC
    Am J Ophthalmol; 1985 Oct; 100(4):507-9. PubMed ID: 2996356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus-III in homosexual men. Selective loss of an influenza-specific, human leukocyte antigen-restricted cytotoxic T lymphocyte response in human T lymphotropic virus-III positive individuals with symptoms of acquired immunodeficiency syndrome and in a patient with acquired immunodeficiency syndrome.
    Shearer GM; Salahuddin SZ; Markham PD; Joseph LJ; Payne SM; Kriebel P; Bernstein DC; Biddison WE; Sarngadharan MG; Gallo RC
    J Clin Invest; 1985 Oct; 76(4):1699-704. PubMed ID: 2997287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Infection of human T-lymphotropic virus type-I (HTLV-I)-bearing MT-4 cells with HTLV-III (AIDS virus): chronological studies of early events.
    Harada S; Koyanagi Y; Yamamoto N
    Virology; 1985 Oct; 146(2):272-81. PubMed ID: 2413616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome.
    Ho DD; Rota TR; Schooley RT; Kaplan JC; Allan JD; Groopman JE; Resnick L; Felsenstein D; Andrews CA; Hirsch MS
    N Engl J Med; 1985 Dec; 313(24):1493-7. PubMed ID: 2999591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation of human T-lymphotropic virus type III from the tears of a patient with the acquired immunodeficiency syndrome.
    Fujikawa LS; Salahuddin SZ; Palestine AG; Masur H; Nussenblatt RB; Gallo RC
    Lancet; 1985 Sep; 2(8454):529-30. PubMed ID: 2412078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human T-cell growth factor (interleukin 2) and gamma-interferon genes: expression in human T-lymphotropic virus type III- and type I-infected cells.
    Arya SK; Gallo RC
    Proc Natl Acad Sci U S A; 1985 Dec; 82(24):8691-5. PubMed ID: 3001715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS.
    Sarngadharan MG; Popovic M; Bruch L; Schüpbach J; Gallo RC
    Science; 1984 May; 224(4648):506-8. PubMed ID: 6324345
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolation of an HTLV-III-related retrovirus from macaques with simian AIDS and its possible origin in asymptomatic mangabeys.
    Murphey-Corb M; Martin LN; Rangan SR; Baskin GB; Gormus BJ; Wolf RH; Andes WA; West M; Montelaro RC
    Nature; 1986 May 22-28; 321(6068):435-7. PubMed ID: 3012358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro.
    Mitsuya H; Weinhold KJ; Furman PA; St Clair MH; Lehrman SN; Gallo RC; Bolognesi D; Barry DW; Broder S
    Proc Natl Acad Sci U S A; 1985 Oct; 82(20):7096-100. PubMed ID: 2413459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Presence of HTLV-III in tears and cells from the eyes of AIDS patients.
    Ablashi DV; Sturzenegger S; Hunter EA; Palestine AG; Fujikawa LS; Kim MK; Nussenblatt RB; Markham PD; Salahuddin SZ
    J Exp Pathol; 1987; 3(4):693-703. PubMed ID: 3483881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of effector mechanisms against HTLV-I- and HTLV-III/LAV-infected lymphoid cells.
    Ruscetti FW; Mikovits JA; Kalyanaraman VS; Overton R; Stevenson H; Stromberg K; Herberman RB; Farrar WL; Ortaldo JR
    J Immunol; 1986 May; 136(10):3619-24. PubMed ID: 2422259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intra-blood-brain-barrier synthesis of HTLV-III-specific IgG in patients with neurologic symptoms associated with AIDS or AIDS-related complex.
    Resnick L; diMarzo-Veronese F; Schüpbach J; Tourtellotte WW; Ho DD; Müller F; Shapshak P; Vogt M; Groopman JE; Markham PD
    N Engl J Med; 1985 Dec; 313(24):1498-504. PubMed ID: 2999592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HTLV-III infection in brains of children and adults with AIDS encephalopathy.
    Shaw GM; Harper ME; Hahn BH; Epstein LG; Gajdusek DC; Price RW; Navia BA; Petito CK; O'Hara CJ; Groopman JE
    Science; 1985 Jan; 227(4683):177-82. PubMed ID: 2981429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostaglandin E2, a seminal constituent, facilitates the replication of acquired immune deficiency syndrome virus in vitro.
    Kuno S; Ueno R; Hayaishi O; Nakashima H; Harada S; Yamamoto N
    Proc Natl Acad Sci U S A; 1986 May; 83(10):3487-90. PubMed ID: 3010301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.